Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kalafatis

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Blood|November 1, 1987
Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factorY Takahashi, M Kalafatis, J P Girma, et al.
Blood|February 1, 1993
Phosphorylation of factor Va and factor VIIIa by activated plateletsM Kalafatis, M D Rand, R J Jenny, et al.
The Journal of Biological Chemistry|August 15, 1997
Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDENC van 't Veer, M Kalafatis, R M Bertina, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactorW R Gould, P Simioni, J R Silveira, et al.
Critical Reviews in Eukaryotic Gene Expression|January 1, 1997
The regulation of clotting factorsM Kalafatis, J O Egan, C van 't Veer, et al.
The Journal of Biological Chemistry|September 1, 1995
The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individualsR M Camire, M Kalafatis, M Cushman, et al.
Thrombosis and Haemostasis|November 1, 2001
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L/propeptide))P Simioni, M Kalafatis, D Tormene, et al.
Blood|August 15, 2000
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic familyE Castoldi, P Simioni, M Kalafatis, et al.
Blood|June 1, 1996
Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assayM Kalafatis, P E Haley, D Lu, et al.
Blood|November 5, 1997
An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN)C van 't Veer, N J Golden, M Kalafatis, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Blood|November 1, 1987
Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factorY Takahashi, M Kalafatis, J P Girma, et al.
Blood|February 1, 1993
Phosphorylation of factor Va and factor VIIIa by activated plateletsM Kalafatis, M D Rand, R J Jenny, et al.
The Journal of Biological Chemistry|August 15, 1997
Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDENC van 't Veer, M Kalafatis, R M Bertina, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2005
Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactorW R Gould, P Simioni, J R Silveira, et al.
Critical Reviews in Eukaryotic Gene Expression|January 1, 1997
The regulation of clotting factorsM Kalafatis, J O Egan, C van 't Veer, et al.
The Journal of Biological Chemistry|September 1, 1995
The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individualsR M Camire, M Kalafatis, M Cushman, et al.
Thrombosis and Haemostasis|November 1, 2001
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L/propeptide))P Simioni, M Kalafatis, D Tormene, et al.
Blood|August 15, 2000
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic familyE Castoldi, P Simioni, M Kalafatis, et al.
Blood|June 1, 1996
Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assayM Kalafatis, P E Haley, D Lu, et al.
Blood|November 5, 1997
An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN)C van 't Veer, N J Golden, M Kalafatis, et al.
Pageof 6